Skip to main content

Table 2 Univariable and multivariable analysis for not being included in cancer patient pathways among colorectal, lung, breast and prostate cancer patients diagnosed in 2015–2016 in Norway

From: Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015–2016

  Colorectal Lung Breast Prostate
Univariate Multivariate Univariate Multivariate Univariate Multivariate Univariate Multivariate
OR [95%CI]* OR [95%CI]* OR [95%CI]* OR [95%CI]* OR [95%CI]* OR [95%CI]* OR [95%CI]* OR [95%CI]*
Year of diagnosis
 2015 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 2016 0.61 [0.55,0.69] 0.60 [0.54,0.68] 0.58 [0.51,0.66] 0.55 [0.47,0.63] 0.33 [0.27,0.41] 0.31 [0.25,0.39] 0.56 [0.51,0.61] 0.51 [0.47,0.56]
 p-value < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Age group
 18–49 2.34 [1.81,3.04] 2.23 [1.70,2.91] 1.06 [0.63,1.78] 1.18 [0.69,2.01] 0.75 [0.55,1.02] 0.77 [0.56,1.06] 0.82 [0.53,1.25] 0.75 [0.48,1.16]
 50–59 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 60–69 0.92 [0.74,1.14] 0.89 [0.72,1.11] 1.02 [0.78,1.33] 1.00 [0.76,1.32] 0.91 [0.70,1.18] 0.88 [0.67,1.15] 0.89 [0.77,1.03] 0.94 [0.81,1.09]
 70–79 1.00 [0.82,1.23] 0.93 [0.75,1.16] 1.19 [0.92,1.54] 1.11 [0.85,1.45] 1.00 [0.74,1.35] 0.79 [0.57,1.10] 1.37 [1.19,1.59] 1.58 [1.35,1.85]
 80–89 1.32 [1.07,1.63] 1.15 [0.92,1.45] 2.63 [2.01,3.44] 2.21 [1.67,2.94] 1.13 [0.80,1.61] 0.74 [0.49,1.10] 4.46 [3.75,5.31] 5.59 [4.60,6.78]
 90+ 3.31 [2.48,4.41] 2.50 [1.83,3.40] 5.39 [3.40,8.55] 4.68 [2.87,7.63] 1.45 [0.84,2.52] 0.92 [0.50,1.68] 14.0 [8.8,22.3] 17.3[10.7,28.0]
 p-value < 0.001 < 0.001 < 0.001 < 0.001 0.138 0.509 < 0.001 < 0.001
Sex
 Female 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]   
 Male 0.87 [0.78,0.97] 0.93 [0.83,1.05] 0.91 [0.80,1.04] 0.86 [0.75,0.99]    1.00 [1.00,1.00] 1.00 [1.00,1.00]
 p-value 0.014 0.240 0.152 0.040     
Stagea
 A 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 B 0.58 [0.50,0.67] 0.57 [0.49,0.66] 1.34 [1.04,1.74] 1.41 [1.09,1.83] 1.01 [0.72,1.40] 1.02 [0.73,1.43] 0.52 [0.46,0.57] 0.44 [0.39,0.49]
 C 1.20 [1.03,1.41] 1.19 [1.01,1.40] 3.25 [2.59,4.08] 3.44 [2.72,4.35] 5.21 [3.77,7.20] 5.94 [4.20,8.40] 1.24 [1.04,1.47] 0.74 [0.61,0.89]
 D 1.41 [1.14,1.73] 1.22 [0.98,1.52] 4.28 [3.31,5.54] 4.08 [3.12,5.32] 3.33 [2.45,4.51] 3.36 [2.41,4.68] 0.86 [0.76,0.96] 0.69 [0.61,0.78]
 p-value < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Marital status
 Single 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 Married 0.71 [0.64,0.79] 0.81 [0.72,0.92] 0.82 [0.72,0.94] 0.93 [0.81,1.08] 1.02 [0.84,1.23] 1.03 [0.83,1.28] 0.89 [0.81,0.97] 0.89 [0.80,0.98]
 p-value < 0.001 < 0.001 0.003 0.351 0.870 0.776 0.010 0.022
Education
 Low 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 Intermediate 0.84 [0.74,0.95] 0.95 [0.83,1.09] 0.85 [0.74,0.98] 0.96 [0.83,1.12] 0.84 [0.66,1.06] 0.92 [0.72,1.18] 0.79 [0.71,0.88] 0.92 [0.82,1.04]
 High 0.85 [0.73,0.99] 0.98 [0.82,1.17] 0.71 [0.57,0.89] 0.88 [0.68,1.13] 0.75 [0.58,0.96] 0.97 [0.72,1.31] 0.81 [0.72,0.92] 1.03 [0.89,1.18]
 p-value 0.015 0.770 0.004 0.592 0.079 0.796 < 0.001 0.120
Income
 Low 1.29 [1.07,1.55] 1.24 [1.00,1.54] 1.97 [1.55,2.51] 1.52 [1.16,1.99] 1.72 [1.27,2.33] 1.42 [0.99,2.03] 1.72 [1.47,2.02] 1.05 [0.87,1.27]
 Intermediate 1.15 [1.00,1.32] 1.13 [0.97,1.33] 1.47 [1.21,1.81] 1.16 [0.93,1.45] 1.39 [1.13,1.72] 1.21 [0.94,1.54] 1.29 [1.18,1.42] 0.94 [0.84,1.05]
 High 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 p-value 0.025 0.146 < 0.001 0.004 < 0.001 0.135 < 0.001 0.310
Regionb
 South-East 1.10 [1.04,1.16] 1.11 [1.05,1.17] 1.07 [1.01,1.14] 1.08 [1.01,1.15] 0.85 [0.78,0.93] 0.85 [0.78,0.93] 0.95 [0.91,0.98] 0.96 [0.92,1.00]
 West 0.93 [0.83,1.04] 0.93 [0.83,1.04] 0.99 [0.88,1.13] 1.01 [0.88,1.15] 1.12 [0.92,1.36] 1.09 [0.89,1.33] 1.41 [1.30,1.53] 1.39 [1.27,1.51]
 Mid 1.10 [0.97,1.25] 1.09 [0.95,1.25] 1.21 [1.02,1.42] 1.22 [1.02,1.45] 2.67 [2.22,3.21] 2.82 [2.32,3.43] 0.76 [0.68,0.85] 0.75 [0.67,0.84]
 North 0.62 [0.51,0.75] 0.59 [0.49,0.72] 0.55 [0.44,0.70] 0.52 [0.41,0.66] 0.48 [0.31,0.75] 0.48 [0.31,0.75] 1.02 [0.89,1.17] 1.04 [0.89,1.20]
 p-value < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Comorbidity         
 No admissions 1.01 [0.75,1.36] 0.97 [0.71,1.32] 0.53 [0.26,1.06] 0.48 [0.23,0.97] 0.74 [0.58,0.96] 0.90 [0.69,1.17] 1.76 [1.55,2.00] 2.00 [1.75,2.29]
 0 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 1–2 1.21 [1.06,1.39] 1.18 [1.02,1.36] 1.23 [1.07,1.41] 1.28 [1.10,1.49] 1.09 [0.79,1.51] 1.07 [0.75,1.51] 1.65 [1.47,1.85] 1.38 [1.22,1.56]
 3+ 1.83 [1.42,2.36] 1.67 [1.28,2.18] 1.95 [1.55,2.45] 1.90 [1.48,2.44] 1.94 [1.02,3.68] 1.09 [0.54,2.19] 3.24 [2.52,4.17] 2.31 [1.75,3.06]
 p-value < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
  1. aColorectal, lung and prostate: Localised (A), Regional (B), Metastasis (C), Unknown (D). Breast: Stage I-II (A), Stage III (B), Stage IV (C), Unknown (D)
  2. bCompared with Norway (mean)
  3. *Odds Ratio [95% c onfidence interval]